For decades prior to the pandemic, dedicated scientists pored over mRNA, learning how this class of molecules works in the body and how it might be leveraged to heal the sick and guard against disease ...

Researchers have developed a new lipid for delivering mRNA that is safer and more effective than current technologies. By changing the chemistry of one key ingredient in lipid nanoparticles (LNPs), ...

The advent of mRNA vaccines against SARS-CoV-2 in 2020 changed the course of the COVID-19 pandemic. Now, the Nobel ...

Add Yahoo as a preferred source to see more of our stories on Google. Elias Sayour (right) and lab members review research data. (CREDIT: UF Health / Jackie Hart) Patients with late-stage lung and ...

HOUSTON – The federal government is ending funding for some vaccine development projects using messenger RNA (mRNA) technology, a move that could affect local researchers and ongoing projects.

Health and Human Services Secretary Robert F. Kennedy Jr. revealed his agency will be cutting funding to mRNA development, calling the vaccine technology "ineffective" and claiming it poses more risks ...

A University of Florida research team led by Elias Sayour, M.D., Ph.D., (center) developed an mRNA vaccine that boosted the tumor-fighting effects of immunotherapy in a mouse-model study. Provided by ...

WASHINGTON (AP) — So-called mRNA vaccines saved millions of lives during the COVID-19 pandemic — and now scientists are using that Nobel Prize-winning technology to try to develop vaccines and ...

Cancer patients who received mRNA COVID vaccines within 100 days of starting immunotherapy were twice as likely to be alive three years after treatment as those who never received a vaccine These ...

mRNA molecule, illustration. [Kateryna Kon/Science Photo Library/Getty Images] Messenger RNA (mRNA) has already transformed medicine, most notably through COVID‑19 vaccines that taught cells to act as ...

Illinois researchers, including some working on vaccines for cancer and rare diseases, worry the federal government turning its back on future development of mRNA vaccines spells more hard times for ...